Alzheimers Disease and its related Dementias (AD/ADRD)-focused Administrative supplements for NIH grants that are not focused on Alzheimers disease.
(NOT-AG-18-008)
National Institute on Aging
John E. Fogarty International Center
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of General Medical Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
National Library of Medicine
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Office of Research on Women's Health
Office of Strategic Coordination (Common Fund)
Next-Generation Biologics for Sustained HIV Remission (R01 Clinical Trial Not Allowed)
(RFA-AI-18-017)
National Institute of Allergy and Infectious Diseases
National Institute of Mental Health
Application Receipt Date(s):
July 27, 2018 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Making Health Care Safer in Ambulatory Care Settings and Long Term Care Facilities (R18)
(PA-18-750)
Agency for Healthcare Research and Quality
Application Receipt Date(s):
Standard dates apply), by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R01 Clinical Trial Optional)
(PA-18-753)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s):
Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R21 Clinical Trials Not Allowed)
(PA-18-754)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s):
Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R21 Clinical Trial Optional)
(PAR-18-745)
National Institute on Minority Health and Health Disparities
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
Office of Research on Women's Health
Application Receipt Date(s):
June 14, 2018, November 14, 2018, June 14, 2019, November 14, 2019, June 15, 2020 and November 13, 2020 by 5:00 PM local time of applicant organization.
Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R01 Clinical Trial Optional)
(PAR-18-747)
National Institute on Minority Health and Health Disparities
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
Office of Research on Women's Health
Application Receipt Date(s):
June 14, 2018, November 14, 2018, June 14, 2019, November 14, 2019, June 15, 2020, November 13, 2020 by 5:00 PM local time of applicant organization.
Examining Diversity, Recruitment and Retention in Aging Research (R24 Clinical Trial Not Allowed)
(PAR-18-749)
National Institute on Aging
Application Receipt Date(s):
Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
NIMH Career Transition Award for Tenure-Track Intramural Investigators (K22 No Independent Clinical Trials)
(PAR-18-755)
National Institute of Mental Health
Application Receipt Date(s):
Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.